Hozefa Amijee

471 total citations
12 papers, 407 citations indexed

About

Hozefa Amijee is a scholar working on Physiology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Hozefa Amijee has authored 12 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Pharmacology and 7 papers in Computational Theory and Mathematics. Recurrent topics in Hozefa Amijee's work include Alzheimer's disease research and treatments (11 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Computational Drug Discovery Methods (7 papers). Hozefa Amijee is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Computational Drug Discovery Methods (7 papers). Hozefa Amijee collaborates with scholars based in United Kingdom. Hozefa Amijee's co-authors include Andrew J. Doig, D. I. C. SCOPES, Kelvin Stott, Jody M. Mason, David A. Middleton, Jillian Madine, J. Mark Treherne, David Spanswick, Ross Jeggo and Eugene O‘Hare and has published in prestigious journals such as Biochemistry, British Journal of Pharmacology and Neurobiology of Aging.

In The Last Decade

Hozefa Amijee

11 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hozefa Amijee United Kingdom	9	323	197	138	129	68	12	407
Sean Spring United States	5	416 1.3×	293 1.5×	92 0.7×	143 1.1×	89 1.3×	6	509
Jennifer Mayes United Kingdom	7	248 0.8×	161 0.8×	69 0.5×	69 0.5×	53 0.8×	7	394
Diane M. Bartley United States	5	277 0.9×	284 1.4×	71 0.5×	121 0.9×	82 1.2×	6	459
Oleksandr Brener Germany	12	270 0.8×	269 1.4×	72 0.5×	92 0.7×	55 0.8×	16	432
Jason Martin United States	5	243 0.8×	236 1.2×	53 0.4×	73 0.6×	66 1.0×	6	355
Emilie Cerf Belgium	4	461 1.4×	373 1.9×	74 0.5×	107 0.8×	153 2.3×	6	640
Christina J. Crump United States	9	312 1.0×	236 1.2×	142 1.0×	158 1.2×	32 0.5×	9	489
Suniba Shuaib India	10	281 0.9×	237 1.2×	92 0.7×	145 1.1×	72 1.1×	13	435
Timothy Johanssen Australia	7	452 1.4×	235 1.2×	109 0.8×	122 0.9×	60 0.9×	8	585
Andres S. Arango United States	8	202 0.6×	196 1.0×	56 0.4×	67 0.5×	61 0.9×	16	412

Countries citing papers authored by Hozefa Amijee

Since Specialization

Citations

This map shows the geographic impact of Hozefa Amijee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hozefa Amijee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hozefa Amijee more than expected).

Fields of papers citing papers by Hozefa Amijee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hozefa Amijee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hozefa Amijee. The network helps show where Hozefa Amijee may publish in the future.

Co-authorship network of co-authors of Hozefa Amijee

This figure shows the co-authorship network connecting the top 25 collaborators of Hozefa Amijee. A scholar is included among the top collaborators of Hozefa Amijee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hozefa Amijee. Hozefa Amijee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

O‘Hare, Eugene, D. I. C. SCOPES, Eun‐Mee Kim, et al.. (2013). Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease. The International Journal of Neuropsychopharmacology. 17(1). 117–126. 10 indexed citations

O‘Hare, Eugene, Ross Jeggo, David Spanswick, et al.. (2012). Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity. British Journal of Pharmacology. 167(2). 383–392. 15 indexed citations

O‘Hare, Eugene, D. I. C. SCOPES, Eun‐Mee Kim, et al.. (2012). Orally bioavailable small molecule drug protects memory in Alzheimer's disease models. Neurobiology of Aging. 34(4). 1116–1125. 14 indexed citations

Amijee, Hozefa, Clive Bate, Alun Williams, et al.. (2012). The N-Methylated Peptide SEN304 Powerfully Inhibits Aβ(1–42) Toxicity by Perturbing Oligomer Formation. Biochemistry. 51(42). 8338–8352. 56 indexed citations

O‘Hare, Eugene, D. I. C. SCOPES, J. Mark Treherne, et al.. (2011). Novel Anti-Inflammatory Compound SEN1176 Alleviates Behavioral Deficits Induced Following Bilateral Intrahippocampal Injection of Aggregated Amyloid-β1-42. Journal of Alzheimer s Disease. 25(2). 219–229. 21 indexed citations

Amijee, Hozefa & D. I. C. SCOPES. (2009). The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease. Journal of Alzheimer s Disease. 17(1). 33–47. 55 indexed citations

Amijee, Hozefa, Jillian Madine, David A. Middleton, & Andrew J. Doig. (2009). Inhibitors of protein aggregation and toxicity. Biochemical Society Transactions. 37(4). 692–696. 55 indexed citations

Doig, Andrew J., Hozefa Amijee, D. I. C. SCOPES, & J. Mark Treherne. (2008). P2‐295: β‐amyloid aggregation inhibitors for the treatment of Alzheimer's disease. Alzheimer s & Dementia. 4(4S_Part_14). 1 indexed citations

SCOPES, D. I. C., Hozefa Amijee, Eugene O‘Hare, et al.. (2008). P2‐358: SEN1269: A novel inhibitor of amyloid‐beta toxicity. Alzheimer s & Dementia. 4(4S_Part_14). 2 indexed citations

10.

Stott, Kelvin, et al.. (2007). N-methylated peptide inhibitors of β-amyloid aggregation and toxicity. Proceedings of The Physiological Society. 8 indexed citations

11.

Stott, Kelvin, et al.. (2006). N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor Structure. Biochemistry. 45(32). 9906–9918. 169 indexed citations

12.

Doig, Andrew J., Kelvin Stott, Hozefa Amijee, et al.. (2006). P4–300: N–methylated peptide inhibitors of β–amyloid aggregation. Alzheimer s & Dementia. 2(3S_Part_20). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact